Translational Oncology

Published by: Elsevier Science, Inc.  

People

  1. Pillarsetty
    Pillarsetty
  2. De Stanchina
    De Stanchina
  3. Grewal
    Grewal
  4. Kalidindi
    Kalidindi
  5. Nikolov
    Nikolov
  6. Pandit-Taskar
    Pandit-Taskar
  7. Schoder
    Schoder
  8. Zanzonico
    Zanzonico

Groups

  1. Radiology, Department of (5)
  2. Radiochemistry and Imaging Sciences Service (3)
  3. GSK Faculty (2)
  4. Molecular Imaging and Therapy Service (2)
  5. Department of Medicine (1)
  6. Genitourinary Oncology Service (1)
  7. Medical Physics (1)
  8. Sloan Kettering Institute Faculty (1)
  9. Sloan Kettering Institute Postdocs (1)
  10. Solid Tumor Oncology Division (1)
Search Within
  1. "Radiology, Department of"
Formats
  1. Journal Article (4)
  2. Review (1)
Groups
  1. Radiology, Department of (5)
  2. Radiochemistry and Imaging Sciences Service (3)
  3. GSK Faculty (2)
  4. Molecular Imaging and Therapy Service (2)
  5. Department of Medicine (1)
  6. Genitourinary Oncology Service (1)

More Groups

People
  1. Nagavarakishore Pillarsetty (2)
  2. Dimitar Nikolov (1)
  3. Dorothea Robev (1)
  4. Elisa De Stanchina (1)
  5. Ellen Ackerstaff (1)
  6. Heiko Schoder (1)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2016 (1)
  4. 2012 (1)
Publishers
  1. Elsevier Science, Inc. (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cyclotron vs generator-produced 68Ga PSMA: A single-institution, prospective clinical trial
    Journal Article

    Martinez, J.; Subramanian, K.; Castellanos, S. H.; Thomas, C.; Choudhury, A. R.; Muench, B.; Tagawa, S. T.; Pillarsetty, N. V. K.; Osborne, J. R.
    Translational Oncology (2023)

    Fulltext@MSK | Save
  • Assessment of salivary gland function after (177)Lu-PSMA radioligand therapy: Current concepts in imaging and management
    Review

    Mahajan, S.; Grewal, R. K.; Friedman, K. P.; Schòˆder, H.; Pandit-Taskar, N.
    Translational Oncology (2022)

    Fulltext@MSK | Save
  • Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
    Journal Article

    Saha, N.; Xu, K.; Zhu, Z.; Robev, D.; Kalidindi, T.; Xu, Y.; Himanen, J.; de Stanchina, E.; Pillarsetty, N. V. K.; Dimitrov, D. S.; more...
    Translational Oncology (2022)

    Fulltext@MSK | Save
  • miR-1207-3p is a novel prognostic biomarker of prostate cancer
    Journal Article

    Das, D. K.; Osborne, J. R.; Lin, H. Y.; Park, J. Y.; Ogunwobi, O. O.
    Translational Oncology (2016)

    Fulltext@MSK | Save
  • Mapping tumor hypoxia in vivo using pattern recognition of dynamic contrast-enhanced MRI data
    Journal Article

    Stoyanova, R.; Huang, K.; Sandler, K.; Cho, H.; Carlin, S.; Zanzonico, P. B.; Koutcher, J. A.; Ackerstaff, E.
    Translational Oncology (2012)

    Fulltext@MSK | Save

    • Translational Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Translational Oncology 19365233 2024
    Translational Oncology 1936-5233 Elsevier Science, Inc.
    Translational Oncology 19365233 Unknown
    Translational Oncology 1936-5233 Elsevier Science, Inc.
    Translational Oncology 1936-5233 Elsevier Science, Inc.
    Translational Oncology 1936-5233 Elsevier Science, Inc.
    Translational Oncology 1944-7124 Neoplasia Press, Inc
    Translational Oncology 19365233 2022
    Translational Oncology 1936-5233 Unknown
    Translational Oncology 19365233 Neoplasia Press, Inc
    Translational Oncology 1936-5233 Neoplasia Press, Inc
    Translational Oncology 19365233 Neoplasia Press, Inc
    Translational Oncology 19365233 2023
    Translational Oncology 1944-7124 Elsevier Science, Inc.
    Translational Oncology 19365233 The Authors
    Translational Oncology 1936-5233 The Authors
    Translational Oncology 1936-5233 Elsevier Inc.
    Translational Oncology 1944-7124 Elsevier Science, Inc.